Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · IEX Real-Time Price · USD
1.100
-0.040 (-3.51%)
At close: May 31, 2024, 4:00 PM
1.120
+0.020 (1.82%)
After-hours: May 31, 2024, 7:37 PM EDT
Clover Health Investments Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for CLOV stock has a target of 1.50, which predicts an increase of 36.36% from the current stock price of 1.10.
Analyst Consensus: Hold
* Price targets were last updated on Aug 11, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for CLOV is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $1 → $1.5 | Hold | Maintains | $1 → $1.5 | +36.36% | Aug 11, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +172.73% | Mar 6, 2023 |
| Credit Suisse | Credit Suisse | Sell Maintains $2.5 → $1.25 | Sell | Maintains | $2.5 → $1.25 | +13.64% | Mar 6, 2023 |
| Citigroup | Citigroup | Hold Maintains $3.5 → $1.8 | Hold | Maintains | $3.5 → $1.8 | +63.64% | Nov 16, 2022 |
| SVB Leerink | SVB Leerink | Hold Maintains $3 → $1.5 | Hold | Maintains | $3 → $1.5 | +36.36% | Nov 8, 2022 |
Financial Forecast
Revenue This Year
1.37B
from 2.03B
Decreased by -32.88%
Revenue Next Year
1.41B
from 1.37B
Increased by 3.15%
EPS This Year
-0.20
from -0.44
EPS Next Year
-0.20
from -0.20
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.4B | 1.5B | 1.6B | 1.6B | 1.7B |
| Avg | 1.4B | 1.4B | 1.5B | 1.5B | 1.7B |
| Low | 1.3B | 1.4B | 1.5B | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -30.6% | 6.4% | 10.9% | 2.4% | 13.9% |
| Avg | -32.9% | 3.2% | 7.7% | -0.5% | 10.7% |
| Low | -35.8% | -1.1% | 3.6% | -4.4% | 6.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.18 | -0.17 | -0.18 | -0.12 | -0.09 |
| Avg | -0.20 | -0.20 | -0.17 | -0.11 | -0.09 |
| Low | -0.23 | -0.22 | -0.17 | -0.11 | -0.09 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.